In the BioHarmony Drug Report Database
Triheptanoin
Dojolvi (triheptanoin) is a small molecule pharmaceutical. Triheptanoin was first approved as Dojolvi on 2020-06-30. Dojolvi’s patent is valid until 2025-10-03 (FDA).
Trade Name
|
Dojolvi |
|---|---|
Common Name
|
triheptanoin |
ChEMBL ID
|
CHEMBL4297585 |
Indication
|
|
Drug Class
|
Glycerolipids |
Image (chem structure or protein)